Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 2,005-2,016 of 4,306
Drug study icon
CompletedNCT03713658

Ability of Conducting a Study of Oral Risperidone Followed by Paliperidone Palmitate in Rwandan Healthcare Facilities

This study is completed in Rwanda. It is testing ability of Conducting a Study of Oral Risperidone Followed by Paliperidone Palmitate for Schizophrenia.

Multiple locations, including Kigali
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 70 Years
Countries
Rwanda
Sponsor
Janssen Research & Development, LLC
Condition
Schizophrenia
Drug study icon
TerminatedNCT01670071

Effect of Oral Paliperidone Extended-Release and Oral Risperidone Immediate-Release on Cognitive Function for schizophrenia

This study was terminated in Taiwan. It is testing Effect of Oral Paliperidone Extended-Release and Oral Risperidone Immediate-Release on Cognitive Function for schizophrenia.

Multiple locations, including Bali Township, Taipei County
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 20 Years to 60 Years
Countries
Taiwan
Sponsor
Johnson & Johnson Taiwan Ltd
Condition
Schizophrenia
Drug study icon
CompletedNCT01730768

Effects of Once Daily Doses of AQW051 on Cognition, in Stable Schizophrenia Patients

This study is completed in the United States. It is testing Effects of Once Daily Doses of AQW051 on Cognition, for schizophrenia.

Multiple locations, including Garden Grove
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Novartis Pharmaceuticals
Condition
Schizophrenia
Drug study icon
CompletedNCT01469039

ALKS 9072 (Also Known for schizophrenia

This study is completed in the United States, in Bulgaria, in Malaysia, .... It is testing ALKS 9072 (Also Known for schizophrenia.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 70 Years
Countries
United States, Bulgaria, Malaysia, ...
Sponsor
Alkermes, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT00866645

Intramuscular Levosulpiride for schizophrenia

This study is completed in China. It is testing intramuscular Levosulpiride for schizophrenia.

Multiple locations, including Baoding
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
China
Sponsor
Shanghai Mental Health Center
Condition
Schizophrenia
Drug study icon
CompletedNCT00817648

Seroquel for schizophrenia

This study is completed in China. It is testing seroquel for schizophrenia.

Multiple locations, including Shanghai
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
China
Sponsor
Shanghai Mental Health Center
Condition
Schizophrenia
Drug study icon
CompletedNCT00250575

Safety and Efficacy of Clozapine for schizophrenia

This study is completed in Japan. It is testing safety and Efficacy of Clozapine for schizophrenia.

Multiple locations, including Chiba
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 64 Years
Countries
Japan
Sponsor
Novartis
Condition
Schizophrenia
Drug study icon
TerminatedNCT02855411

Safety study of Safety And Efficacy Of PF-04958242 in schizophrenia

This study was terminated in the United States. It is testing Safety And Efficacy Of PF-04958242 for schizophrenia.

Multiple locations, including Garden Grove
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 50 Years
Countries
United States
Sponsor
Biogen
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.